General description

A β-lactam antibiotic that inhibits bacterial cell-wall synthesis. Active against Gram-negative bacteria. Inactivated by lactamases. Suitable for use in research that uses ampicillin-resistant plasmids.

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Other Notes

Nakajima, M., et al. 1994. Neurosci. Lett.176, 161.Wu, M.H., and Yung, B.Y. 1994. Eur. J. Pharmacol.270, 203.Betzel, C., et al. 1993. Biochim. Biophys. Acta1161, 47.Yung, B.Y., et al. 1992. Int. J. Cancer52, 317.Martin, S.J., et al. 1990. J. Immunol.145, 1859.Yung, B.Y., et al. 1990. Cancer Res.50, 5987.White, R.J., and Phillips, D.R. 1985. Biochemistry27, 9122.Madharavao, M., et al. 1978. J. Med. Chem.21, 958.Sengupta, S.K., et al. 1975. J. Med. Chem.18, 1175.

Packaging

10 ml in Glass bottle

Physical form

Supplied at 100 mg/ml in H₂O.

Reconstitution

Following initital thaw, aliquot and freeze (-20°).

Warning

Toxicity: Harmful (C)